Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

August 2016 - FRMC

Department
Studies Show Gene Profiling Increases Treatment Response, Reduces Costs
08/15/2016
Two studies presented at the EULAR 2016 Congress showed that gene profiling can be used to quickly identify which rheumatoid arthritis (RA) patients are not responding to therapies, decreasing long-term joint damage and avoiding costs wasted...
Two studies presented at the EULAR 2016 Congress showed that gene profiling can be used to quickly identify which rheumatoid arthritis (RA) patients are not responding to therapies, decreasing long-term joint damage and avoiding costs wasted...
Two studies presented at the...
08/15/2016
First Report Managed Care
Department
Remicade Cross-reaction Suggests Switching to Biosimilars Not Optimal for All Patients
08/15/2016
Antibodies produced in response to the biological treatment Remicade cross (infliximab; Janssen Biotech) react with antibodies produced by the drug’s biosimilars, suggesting that patients treated with Remicade should not be switched to a...
Antibodies produced in response to the biological treatment Remicade cross (infliximab; Janssen Biotech) react with antibodies produced by the drug’s biosimilars, suggesting that patients treated with Remicade should not be switched to a...
Antibodies produced in response...
08/15/2016
First Report Managed Care
Department
Patient Participation in Health Care Planning Optimizes Outcomes
08/15/2016
Researchers who presented data at the EULAR 2016 Congress found that stimulating a team relationship between health care providers (HCPs) and patients regarding treatment planning may help to improve patient outcomes.  
Researchers who presented data at the EULAR 2016 Congress found that stimulating a team relationship between health care providers (HCPs) and patients regarding treatment planning may help to improve patient outcomes.  
Researchers who presented data...
08/15/2016
First Report Managed Care
Department
Discontinuation Rates Low Among Patients Taking Xeljanz Monotherapy for RA
08/15/2016
Patients treated with Xeljanz (tofacitinib) monotherapy for long-term treatment of rheumatoid arthritis had low rates of discontinuation.
Patients treated with Xeljanz (tofacitinib) monotherapy for long-term treatment of rheumatoid arthritis had low rates of discontinuation.
Patients treated with Xeljanz...
08/15/2016
First Report Managed Care
Department
Adding Integrated Care Pharmacist May Reduce 30-day Readmission Rates
08/15/2016
According to a poster presentation at the ASHP 2016 Summer Meetings & Exhibition, the addition of an integrated care pharmacists at a community hospital helped to improve care transitions, reduce 30-day readmissions, and reduce health care...
According to a poster presentation at the ASHP 2016 Summer Meetings & Exhibition, the addition of an integrated care pharmacists at a community hospital helped to improve care transitions, reduce 30-day readmissions, and reduce health care...
According to a poster...
08/15/2016
First Report Managed Care
Department
Costs of Innovative Drugs High in Primary Care
08/15/2016
Recently, FDA-approved direct-acting antiviral drugs that attack the hepatitis C virus (HCV) have improved success rates for individuals, with cure rates over 90% in most patients.
Recently, FDA-approved direct-acting antiviral drugs that attack the hepatitis C virus (HCV) have improved success rates for individuals, with cure rates over 90% in most patients.
Recently, FDA-approved...
08/15/2016
First Report Managed Care
Department
Key Health Care Issues Impacting Pharmacy
08/15/2016
Many critical health care issues at the federal and state levels will impact health-system pharmacists. Attendees at ASHP 2016 Summer Meetings & Exhibition were updated on some of the key issues facing pharmacists during a session that...
Many critical health care issues at the federal and state levels will impact health-system pharmacists. Attendees at ASHP 2016 Summer Meetings & Exhibition were updated on some of the key issues facing pharmacists during a session that...
Many critical health care issues...
08/15/2016
First Report Managed Care
Department
Challenges of Limited Distribution Drugs in 340B Program
08/15/2016
The federal 340B drug discount program remains an essential component to ensuring that safety-net hospitals have access to affordable medication, but this program has received unprecedented scrutiny from Congress and the drug industry in...
The federal 340B drug discount program remains an essential component to ensuring that safety-net hospitals have access to affordable medication, but this program has received unprecedented scrutiny from Congress and the drug industry in...
The federal 340B drug discount...
08/15/2016
First Report Managed Care
Department
Clinical Documentation Critical to Pharmacy`s Success
08/15/2016
The newly developed health care environment demands the use of standardized terminologies and coding systems for clinical documentation.
The newly developed health care environment demands the use of standardized terminologies and coding systems for clinical documentation.
The newly developed health care...
08/15/2016
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

Conference Insider
Patient-Reported Outcomes Similarly Impacted By Migraine Treatments
05/17/2019
Researchers recently found that patient-reported outcomes (PROs) were no different among patients treated with calcitonin gene-related peptide (CGRP) antagonists or onabotulinumtoxinA (ONA) for the indication of chronic migraine prophylaxis. 
Researchers recently found that patient-reported outcomes (PROs) were no different among patients treated with calcitonin gene-related peptide (CGRP) antagonists or onabotulinumtoxinA (ONA) for the indication of chronic migraine prophylaxis. 
Researchers recently found that...
05/17/2019
First Report Managed Care
News
Cancer`s growing burden: the high cost of care
03/02/2012
03/02/2012
First Report Managed Care
Mergers Pave Way for Good Opportunity to Enter Medicare Advantage Market
11/06/2015
While the largest insurance companies await their fate at the hands of federal regulators, other plans and investors should pay close attention to the opportunity to acquire divested plans from the two deals.
While the largest insurance companies await their fate at the hands of federal regulators, other plans and investors should pay close attention to the opportunity to acquire divested plans from the two deals.
While the largest insurance...
11/06/2015
First Report Managed Care
News
Trial to Test CAR T-Cell Therapy for Refractory Progressive MS
03/18/2024
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19...
03/18/2024
First Report Managed Care
News
Cost-Effective Treatment Option for Tremor-Dominant Parkinson Disease
10/13/2020
Magnetic resonance-guided focused ultrasound thalamotomy is more cost-effective than continued medical therapy for patients with tremor-dominant Parkinson disease.
Magnetic resonance-guided focused ultrasound thalamotomy is more cost-effective than continued medical therapy for patients with tremor-dominant Parkinson disease.
Magnetic resonance-guided...
10/13/2020
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

August 2016 Volume 13 Issue 8

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement